Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2023 is -43.09% vs -8.14% in Mar 2022
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2023 is -270.44% vs 76.12% in Mar 2022
Interest
YoY Growth in year ended Mar 2023 is 25.92% vs 17.04% in Mar 2022
Profit After Tax
YoY Growth in year ended Mar 2023 is -94.85% vs 51.67% in Mar 2022
Compare Profit and Loss Results of Bharat Immunolog
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
44.00
42.00
2.00
4.76%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
44.00
42.00
2.00
4.76%
Expenditure (Ex Depriciation)
Stock Adjustments
5.00
3.00
2.00
66.67%
Raw Materials Consumed
33.00
19.00
14.00
73.68%
Power & Fuel Cost
1.00
4.00
-3.00
-75.00%
Employee Cost
15.00
9.00
6.00
66.67%
Operating Expenses
3.00
2.00
1.00
50.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
1.00
-1.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
1.00
1.00
100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
63.00
45.00
18.00
40.00%
Operating Profit (PBDIT) excl Other Income
-18.00
-2.00
-16.00
-800.00%
Other Income
2.00
10.00
-8.00
-80.00%
Operating Profit (PBDIT)
-15.00
8.00
-23.00
-287.50%
Interest
7.00
0.00
7.00
0%
Profit before Depriciation and Tax
-22.00
7.00
-29.00
-414.29%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
-22.00
4.00
-26.00
-650.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-22.00
4.00
-26.00
-650.00%
Provision for Tax
-5.00
0.00
-5.00
0%
Profit After Tax
-17.00
4.00
-21.00
-525.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-49.00
15.00
-64.00
-426.67%
Profit Available for appropriations
-66.00
20.00
-86.00
-430.00%
Appropriations
-66.00
20.00
-86.00
-430.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-3.95
7.87
-11.82
-150.19%
Profit And Loss - Net Sales
Net Sales 44.61 Cr
in Mar 2023Figures in Cr
YoY Growth in year ended Mar 2023 is -43.09% vs -8.14% in Mar 2022
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -18.47 Cr
in Mar 2023Figures in Cr
YoY Growth in year ended Mar 2023 is -270.44% vs 76.12% in Mar 2022
Profit And Loss - Interest
Interest 7.04 Cr
in Mar 2023Figures in Cr
YoY Growth in year ended Mar 2023 is 25.92% vs 17.04% in Mar 2022
Profit And Loss - Profit After Tax
Profit After Tax -17.06 Cr
in Mar 2023Figures in Cr
YoY Growth in year ended Mar 2023 is -94.85% vs 51.67% in Mar 2022






